Yukihiko Sonoda

11PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 31, 2026
Prognostic impact of RANO resect group classification post-chemoradiotherapy in IDH-wildtype glioblastoma.

|Aug 28, 2025
HDAC Class I Inhibitor Domatinostat Induces Apoptosis Preferentially in Glioma Stem Cells Through p53-Dependent and -Independent Activation of BAX Expression.

Yurika Nakagawa-Saito, Yasufumi Ito, Kazuki Nakamura

|Jul 29, 2025
Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells.

Senri Takenouchi, Yasufumi Ito, Kazuki Nakamura

|Sep 14, 2024
CEP-1347 Boosts Chk2-Mediated p53 Activation by Ionizing Radiation to Inhibit the Growth of Malignant Brain Tumor Cells.

Yuta Mitobe, Shuhei Suzuki, Kazuki Nakamura

|Jul 27, 2021
A surgical case of pediatric spinal medulloepithelioma.

Kazuki Nakamura, Ken-Ichiro Matsuda, Takanobu Kabasawa

|Feb 06, 2020
Relationships between recurrence patterns and subventricular zone involvement or CD133 expression in glioblastoma.

Tetsu Yamaki, Ichiyo Shibahra, Ken-Ichiro Matsuda

Pageof 2

Frequent Collaborators

3 joint publications

Yurika Nakagawa-Saito

3 joint publications

Masashi Okada

2 joint publications

Shuhei Suzuki